BASKING RIDGE, N.J., Oct. 4, 2017 /PRNewswire/ -- Daiichi Sankyo, Inc. today announced the establishment of Commitments in Pain Care, a program focused on education and awareness about responsible ...

Daiichi Sankyo, Inc. jbrennan2@dsi.com +1 973 944 2393 (office) +1 201 709 9309 (mobile) Markets Insider and Business Insider Editorial Teams were not involved in the creation of this post.

Daiichi Sankyo and Kite have now agreed that the Marketing Authorization for Yescarta will be transferred to Gilead Sciences K.K., the Japan subsidiary of Gilead Sciences, Inc., in 2023.

TOKYO& BASKING RIDGE, N.J.---- Daiichi Sankyo Co., Ltd. announced today that the U.S. Patent and Trademark Office rendered a Final Written Decision invalidating all claims of Seagen Inc.’ s U.S ...

Daiichi Sankyo Co. Ltd. <4568.T>, Japan's second-largest drug maker, said on Wednesday it planned to more than double its U.S. sales staff, seeking to capitalise on a wealth of new drugs expected ...